Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 02, 2015 5:48 PM ET

Pharmaceuticals

Company Overview of Ceptaris Therapeutics, Inc.

Executive Profile

Stephen A. Tullman

Chairman and Chief Executive Officer, Ceptaris Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 7 different industries.

See Board Relationships
----

Background

Mr. Stephen A. Tullman, also known as Steve, is the Managing Partner of NeXeption, LLC. Mr. Tullman is a Founding Partner of Celaris Therapeutics. Mr. Tullman has more than 25 years of biopharmaceutical global commercialization and drug development experience. Mr. Tullman served as the Chairman and Chief Executive Officer of Ceptaris Therapeutics, Inc. (formerly, Yaupon Therapeutics, Inc.) since May 9, 2011. He Co-founded Ception Therapeutics, Inc. in 2004 and served ...

Corporate Headquarters

101 Lindenwood Drive
Malvern, Pennsylvania 19355

United States

Phone: 610-975-9290
Fax: 610-975-9012

Board Members Memberships

Co-Founder, Chief Executive Officer, President and Director
Executive Chairman
Chairman of The Board
Chairman of the Board
Director
2011-Present
Chairman and Chief Executive Officer

Education

BS
Rutgers, The State University of New Jersey

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ceptaris Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.